Viatris, Inc.

VTRS Healthcare
$13.44
Market Cap $15.48B
P/E Ratio
Forward P/E 5.04
Dividend Yield 3.57%
Beta 0.82
52W Range $6.94 - $15.99
# Hedge Funds 2
Sector Healthcare
Industry Drug Manufacturers - Specialty & Generic

Hedge Fund Ownership

2 funds holding this stock
Investor 2 % of Portfolio i Weight of this stock in the investor's portfolio Value i Total dollar value of the position Shares i Number of shares held Activity i Portfolio change type: New, Increased, Decreased, or Sold
Christopher Davis Davis Selected Advisers 4.37% $973.32M 78,177,984 Add 12.74%
Bill Miller Miller Value Partners 2.72% $7.71M 619,000

Insider Trading

2 transactions in the last 6 months
Insider i Name of the company insider who made the trade 2 Type i Purchase (buy) or Sale (sell) Shares i Number of shares traded Price i Price per share at time of transaction Value i Total dollar value of the transaction Trade Date i Date the transaction was executed Filing Date i Date the SEC filing was submitted
Campbell PaulSee RemarksSale21,350$13.28$283.54K23 Mar 202623 Mar 2026
SIMMONS DAVID SBuy213$10.43$2.22K03 Nov 202527 Aug 2025

Frequently Asked Questions

What is VTRS stock price today?

Viatris, Inc. (VTRS) is currently trading at $13.44. The stock has a 52-week range of $6.94 to $15.99 and a market capitalization of $15.48B.

Is VTRS a good stock to buy in 2026?

Viatris, Inc. has a P/E ratio of N/A (forward P/E: 5.0), a dividend yield of 3.57%, and 1-year performance of +72.3%. 2 hedge funds hold this stock. Review the fundamentals and ownership data above to make an informed decision.

Are insiders buying or selling VTRS stock?

There have been 2 insider transactions for VTRS in recent months. Insider buys can signal management confidence, while sales may reflect diversification or personal financial planning. Check the Insider Trading section above for details.

How has VTRS stock performed over the past year?

Viatris, Inc. (VTRS) has returned +72.3% over the past 12 months. The stock traded between $6.94 and $15.99 during this period, and is currently at $13.44.

Which hedge funds own VTRS (Viatris, Inc.)?

2 tracked hedge funds currently hold VTRS in their portfolios as of the latest 13F filings. See the ownership table above for the complete list.

What is VTRS's market cap and valuation?

Viatris, Inc. (VTRS) has a market capitalization of $15.48B. The trailing P/E ratio is N/A and forward P/E is 5.0. The stock is classified in the Healthcare sector.

What is VTRS's revenue and profitability?

Viatris, Inc. reported revenue of $14.30B with net income of N/A and a profit margin of N/A. The stock has a beta of 0.82.

What sector is VTRS in and who are its biggest institutional holders?

Viatris, Inc. (VTRS) operates in the Healthcare sector. It is held by 2 tracked hedge funds. See the ownership table above for the complete list.